NPI: 1063497451 · RARITAN, NJ 08869 · Clinical Medical Laboratory · NPI assigned 12/08/2005
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 12/08/2005 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,616,246 | $70.63M |
| 2019 | 10,963,670 | $71.99M |
| 2020 | 12,452,401 | $100.76M |
| 2021 | 18,749,575 | $139.71M |
| 2022 | 20,133,124 | $129.95M |
| 2023 | 18,497,084 | $110.93M |
| 2024 | 18,043,632 | $93.50M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,409,066 | 1,160,096 | $99.27M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,270,062 | 1,330,574 | $44.22M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,732,716 | 2,577,686 | $36.30M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,718,271 | 2,564,191 | $34.22M |
| 80050 | General health panel | 1,455,823 | 1,388,914 | $33.10M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,911,722 | 2,762,137 | $23.66M |
| 80061 | Lipid panel | 5,567,718 | 5,316,042 | $20.85M |
| 86480 | 699,333 | 678,643 | $18.51M | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 839,388 | 662,252 | $16.87M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 49,105 | 47,718 | $15.28M |
| 80053 | Comprehensive metabolic panel | 5,649,014 | 5,294,631 | $14.99M |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 86,086 | 82,899 | $14.56M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,707,214 | 1,638,927 | $14.45M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,432,602 | 1,346,747 | $13.08M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 494,395 | 250,235 | $12.40M |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,527,902 | 4,309,232 | $11.22M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 611,389 | 580,021 | $10.59M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 680,647 | 554,695 | $10.04M |
| 84443 | Thyroid stimulating hormone (TSH) | 3,482,722 | 3,319,912 | $9.68M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 104,062 | 98,414 | $9.50M |
| 86769 | 245,905 | 229,538 | $9.49M | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,745,427 | 5,432,385 | $9.47M |
| 87536 | 220,843 | 213,932 | $8.34M | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 649,353 | 630,266 | $7.79M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 848,189 | 820,062 | $7.50M |
| 82607 | 1,332,083 | 1,277,811 | $6.48M | |
| 86803 | 1,216,726 | 1,156,605 | $6.09M | |
| 84439 | 1,913,644 | 1,821,878 | $4.85M | |
| 86003 | 170,628 | 158,175 | $4.36M | |
| 82746 | 940,704 | 903,398 | $4.30M | |
| 83655 | 863,949 | 847,096 | $3.81M | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,516,370 | 1,397,469 | $3.76M |
| 86235 | 119,472 | 114,214 | $3.72M | |
| 87340 | 925,718 | 885,931 | $3.35M | |
| 82728 | 931,487 | 881,141 | $3.31M | |
| 84153 | 597,895 | 570,031 | $3.30M | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 105,075 | 97,471 | $3.25M |
| 86360 | 136,841 | 134,141 | $3.20M | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 33,907 | 32,269 | $3.04M |
| 84403 | 333,776 | 318,679 | $2.90M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 89,669 | 83,533 | $2.82M |
| 80074 | 245,026 | 231,561 | $2.56M | |
| 85027 | 1,133,369 | 1,039,522 | $2.48M | |
| 80081 | 51,471 | 45,779 | $2.41M | |
| 81001 | 1,883,540 | 1,798,472 | $2.24M | |
| 86592 | 1,531,485 | 1,472,239 | $2.22M | |
| 83013 | 100,157 | 97,940 | $2.22M | |
| 86706 | 537,348 | 512,876 | $2.17M | |
| 87522 | Neg quan hep c or qual rna | 141,772 | 129,993 | $2.07M |
| 83550 | 939,358 | 892,579 | $1.98M | |
| 87081 | 786,850 | 752,267 | $1.83M | |
| 84402 | 218,136 | 209,077 | $1.81M | |
| 82043 | 1,027,524 | 988,263 | $1.79M | |
| 86787 | 314,540 | 307,083 | $1.79M | |
| 81329 | 66,309 | 64,270 | $1.77M | |
| 82670 | 178,985 | 169,503 | $1.76M | |
| 83540 | 1,069,989 | 1,013,559 | $1.75M | |
| 87902 | 23,291 | 20,979 | $1.75M | |
| 86762 | 339,016 | 330,891 | $1.73M | |
| 84146 | 248,898 | 237,533 | $1.70M | |
| 83001 | 264,914 | 253,457 | $1.65M | |
| 86780 | 275,225 | 267,747 | $1.62M | |
| 86704 | 367,362 | 356,768 | $1.60M | |
| 83970 | 154,318 | 147,583 | $1.57M | |
| 84480 | 380,689 | 367,769 | $1.56M | |
| 86696 | 229,674 | 220,828 | $1.54M | |
| 83002 | 239,296 | 228,813 | $1.52M | |
| 86765 | 238,435 | 233,849 | $1.41M | |
| 82570 | 940,071 | 893,569 | $1.40M | |
| 86618 | 178,685 | 170,955 | $1.40M | |
| 86038 | 379,409 | 363,722 | $1.32M | |
| 84436 | 750,564 | 719,597 | $1.31M | |
| 80048 | Basic metabolic panel (calcium, ionized) | 706,726 | 656,708 | $1.30M |
| 84702 | 334,968 | 280,512 | $1.29M | |
| 86708 | 266,676 | 259,328 | $1.28M | |
| 87186 | 425,794 | 400,444 | $1.28M | |
| 86735 | 221,406 | 217,296 | $1.26M | |
| 87150 | 104,286 | 99,581 | $1.20M | |
| 81003 | 1,859,827 | 1,805,558 | $1.19M | |
| 87070 | 385,062 | 363,963 | $1.18M | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 75,697 | 71,853 | $1.14M |
| 82784 | 238,288 | 228,258 | $1.12M | |
| 86317 | 232,957 | 227,940 | $1.11M | |
| 84481 | 215,521 | 206,359 | $1.05M | |
| 83516 | 137,380 | 131,329 | $995K | |
| 87077 | 357,137 | 337,168 | $965K | |
| 86376 | 201,612 | 194,463 | $950K | |
| 86617 | 85,733 | 81,889 | $939K | |
| 87088 | 415,982 | 389,233 | $937K | |
| 87901 | 5,475 | 5,296 | $936K | |
| 86665 | 75,706 | 72,952 | $935K | |
| 83735 | 518,792 | 450,234 | $934K | |
| 82274 | 172,882 | 168,661 | $916K | |
| 87507 | 11,028 | 10,537 | $911K | |
| 84144 | 115,650 | 99,917 | $908K | |
| 86140 | 583,991 | 535,775 | $892K | |
| 86695 | 204,522 | 196,979 | $866K | |
| 87563 | 69,392 | 65,652 | $856K | |
| 36415 | Collection of venous blood by venipuncture | 4,740,680 | 4,219,760 | $834K |
| 84479 | 470,161 | 452,641 | $808K | |
| 82627 | 101,167 | 98,050 | $792K | |
| 84550 | 590,473 | 565,470 | $787K | |
| 83021 | 94,061 | 91,691 | $779K | |
| 87480 | 81,656 | 78,142 | $778K | |
| 88142 | 79,760 | 76,761 | $767K | |
| 84154 | 120,366 | 117,294 | $765K | |
| 87510 | 80,728 | 77,215 | $758K | |
| 87660 | 80,537 | 77,067 | $756K | |
| 82248 | 321,693 | 295,128 | $754K | |
| 86800 | 149,702 | 144,826 | $751K | |
| 80055 | 18,458 | 17,781 | $731K | |
| 82652 | 89,066 | 84,597 | $697K | |
| 80348 | 296,546 | 245,668 | $692K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 9,224 | 7,971 | $657K |
| 87625 | 25,640 | 24,251 | $648K | |
| 87529 | 60,372 | 57,517 | $639K | |
| 86364 | 92,817 | 88,706 | $597K | |
| 83020 | 137,169 | 131,560 | $595K | |
| 80076 | 417,033 | 397,853 | $584K | |
| 86225 | 138,277 | 133,042 | $579K | |
| 86361 | 66,963 | 64,490 | $577K | |
| 82785 | 124,750 | 121,255 | $571K | |
| 86160 | 89,595 | 85,807 | $565K | |
| 83880 | 65,831 | 59,924 | $564K | |
| 85652 | 705,977 | 655,666 | $559K | |
| 86008 | 25,553 | 24,107 | $538K | |
| 87900 | 9,802 | 9,499 | $534K | |
| 81243 | 40,888 | 39,395 | $526K | |
| 88185 | 4,157 | 4,036 | $516K | |
| 87209 | 77,937 | 71,226 | $514K | |
| 86147 | 30,225 | 28,969 | $512K | |
| 88112 | 25,239 | 23,592 | $507K | |
| 82977 | 267,927 | 248,992 | $503K | |
| 88141 | 84,819 | 81,713 | $488K | |
| 83525 | 118,342 | 113,735 | $487K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 7,157 | 6,229 | $472K |
| 84100 | 371,529 | 334,501 | $463K | |
| 82565 | 358,457 | 342,258 | $462K | |
| 86431 | 275,473 | 265,463 | $462K | |
| 85610 | 472,655 | 386,237 | $458K | |
| 84450 | 352,814 | 332,399 | $454K | |
| 86359 | 41,470 | 40,675 | $451K | |
| 87906 | 4,913 | 4,766 | $436K | |
| 82947 | 382,447 | 368,001 | $422K | |
| 82105 | 140,663 | 136,116 | $413K | |
| 81374 | 21,344 | 20,083 | $412K | |
| 87650 | 32,012 | 30,358 | $407K | |
| 84445 | 29,596 | 28,837 | $403K | |
| 87517 | 36,160 | 34,947 | $402K | |
| 86200 | 114,131 | 110,062 | $391K | |
| 84075 | 265,366 | 254,979 | $377K | |
| 83615 | 232,624 | 216,041 | $377K | |
| 84460 | 267,377 | 249,880 | $371K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 24,426 | 23,205 | $357K |
| 82310 | 265,055 | 255,474 | $355K | |
| 84520 | 332,907 | 318,571 | $353K | |
| 82533 | 68,885 | 64,672 | $352K | |
| 82465 | 243,470 | 238,715 | $346K | |
| 82550 | 171,487 | 159,383 | $345K | |
| 81229 | 4,309 | 4,249 | $344K | |
| 82247 | 288,882 | 276,947 | $344K | |
| 86258 | 40,373 | 38,707 | $342K | |
| 87338 | 73,726 | 71,774 | $340K | |
| 0099U | 2,765 | 2,713 | $332K | |
| 88342 | 12,079 | 11,500 | $329K | |
| 82040 | 272,016 | 261,741 | $319K | |
| 86709 | 66,711 | 64,329 | $315K | |
| 86141 | 71,273 | 69,026 | $313K | |
| 86664 | 56,535 | 54,882 | $303K | |
| 85730 | 253,712 | 238,748 | $302K | |
| 83498 | 32,638 | 31,683 | $302K | |
| 87481 | 22,534 | 21,209 | $294K | |
| 86850 | 152,534 | 146,220 | $288K | |
| 84295 | 230,094 | 221,799 | $287K | |
| 86231 | 62,003 | 59,261 | $285K | |
| 85660 | 148,522 | 144,909 | $283K | |
| 84681 | 38,260 | 36,912 | $279K | |
| 86255 | 60,335 | 58,871 | $278K | |
| 86334 | 37,002 | 35,241 | $278K | |
| 80349 | 110,025 | 74,243 | $277K | |
| 86747 | 22,835 | 22,081 | $275K | |
| 82024 | 22,948 | 21,672 | $275K | |
| 83690 | 134,657 | 128,685 | $275K | |
| 82950 | 194,479 | 184,262 | $274K | |
| 87535 | 19,734 | 18,820 | $268K | |
| 84305 | 36,940 | 36,007 | $266K | |
| 87427 | 62,153 | 59,284 | $265K | |
| 82435 | 228,643 | 220,617 | $262K | |
| 80164 | 63,751 | 59,008 | $258K | |
| 82378 | 51,204 | 46,963 | $255K | |
| 88341 | 7,955 | 7,562 | $255K | |
| 87177 | 78,269 | 71,454 | $254K | |
| 84270 | 37,264 | 36,243 | $252K | |
| 84155 | 281,704 | 271,385 | $251K | |
| 86146 | 19,975 | 19,156 | $249K | |
| 88312 | 16,376 | 15,823 | $245K | |
| 84132 | 202,314 | 194,987 | $244K | |
| 82672 | 29,521 | 28,569 | $242K | |
| 83090 | 41,655 | 39,627 | $241K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 21,667 | 21,161 | $240K |
| 84425 | 46,344 | 44,767 | $237K | |
| 82172 | 47,580 | 44,462 | $235K | |
| 87255 | 18,640 | 17,877 | $233K | |
| 88262 | 6,772 | 6,653 | $232K | |
| 88304 | 29,105 | 28,142 | $228K | |
| 83721 | 94,021 | 89,919 | $226K | |
| 83521 | 17,689 | 16,473 | $225K | |
| 83520 | 64,905 | 62,814 | $225K | |
| 86705 | 63,696 | 61,442 | $221K | |
| 88230 | 7,052 | 6,915 | $215K | |
| 81596 | 19,904 | 19,397 | $213K | |
| 86677 | 27,476 | 26,411 | $213K | |
| 84165 | 66,443 | 63,386 | $208K | |
| 87045 | 62,361 | 59,463 | $207K | |
| 81490 | 3,219 | 2,998 | $206K | |
| 86355 | 19,809 | 19,484 | $206K | |
| 82626 | 21,772 | 21,189 | $205K | |
| 82150 | 106,068 | 101,531 | $205K | |
| 86645 | 27,054 | 26,180 | $204K | |
| 81401 | 6,538 | 6,414 | $204K | |
| 86644 | 29,824 | 28,801 | $194K | |
| 87046 | 62,644 | 59,622 | $192K | |
| 84156 | 206,628 | 190,560 | $191K | |
| 83921 | 33,494 | 32,012 | $191K | |
| 87521 | Neg quan hep c or qual rna | 11,965 | 10,631 | $185K |
| 81257 | 10,977 | 10,505 | $180K | |
| 82951 | 47,973 | 45,738 | $177K | |
| 88344 | 3,227 | 3,067 | $175K | |
| 86777 | 30,611 | 30,018 | $175K | |
| 87350 | 43,989 | 42,944 | $174K | |
| 80197 | 48,743 | 37,036 | $171K | |
| 86901 | 214,638 | 206,505 | $170K | |
| 87075 | 48,357 | 45,667 | $168K | |
| 80321 | 34,088 | 24,668 | $167K | |
| 86707 | 38,514 | 37,720 | $160K | |
| 86702 | 28,936 | 27,857 | $155K | |
| 80299 | 12,700 | 11,668 | $154K | |
| 86900 | 207,867 | 199,724 | $152K | |
| 84466 | 42,270 | 39,548 | $150K | |
| 84703 | 62,140 | 57,707 | $146K | |
| 86666 | 11,358 | 10,857 | $143K | |
| 80051 | 75,107 | 71,936 | $141K | |
| 80346 | 64,942 | 52,706 | $139K | |
| 85045 | 114,362 | 109,377 | $137K | |
| 86694 | 35,048 | 34,373 | $137K | |
| 84207 | 18,034 | 17,500 | $135K | |
| 86060 | 45,678 | 44,420 | $134K | |
| 86304 | 24,645 | 22,721 | $133K | |
| 80358 | 244,835 | 211,090 | $130K | |
| 82157 | 13,131 | 12,871 | $128K | |
| 81381 | 4,827 | 4,705 | $127K | |
| 87497 | 9,756 | 7,359 | $127K | |
| 82088 | 12,529 | 12,011 | $123K | |
| 83883 | 35,125 | 33,849 | $123K | |
| 84410 | 6,187 | 6,026 | $121K | |
| 86037 | 13,921 | 13,411 | $121K | |
| 82397 | 26,683 | 25,944 | $120K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4,690 | 4,526 | $116K |
| 84630 | 35,210 | 34,271 | $115K | |
| 82985 | 36,297 | 34,679 | $114K | |
| 80365 | 224,136 | 198,823 | $114K | |
| 86381 | 14,005 | 13,532 | $114K | |
| 86593 | 47,826 | 46,147 | $113K | |
| 80361 | 255,765 | 219,266 | $113K | |
| 84432 | 15,963 | 15,306 | $112K | |
| 86300 | 16,717 | 15,268 | $112K | |
| 86701 | 27,026 | 26,009 | $111K | |
| 81025 | 48,753 | 44,210 | $110K | |
| 81479 | Unlisted molecular pathology procedure | 2,295 | 1,632 | $108K |
| 80069 | 59,061 | 52,930 | $108K | |
| 86753 | 11,270 | 10,812 | $107K | |
| 80178 | 42,482 | 38,401 | $106K | |
| 80354 | 271,172 | 224,455 | $105K | |
| 87329 | 25,505 | 24,350 | $104K | |
| 86671 | 15,193 | 14,840 | $104K | |
| 87101 | 38,945 | 37,273 | $103K | |
| 87324 | 27,714 | 26,568 | $102K | |
| 84478 | 76,686 | 66,820 | $101K | |
| 86663 | 21,192 | 20,710 | $101K | |
| 87493 | 8,136 | 7,880 | $100K | |
| 87799 | 11,038 | 9,631 | $100K | |
| 86301 | 18,843 | 17,263 | $97K | |
| 86738 | 8,493 | 8,188 | $95K | |
| 83993 | 26,880 | 25,987 | $94K | |
| 86778 | 19,962 | 19,525 | $94K | |
| 80177 | 24,134 | 23,426 | $91K | |
| 86341 | 10,820 | 10,242 | $90K | |
| 81377 | 3,850 | 3,738 | $90K | |
| 86256 | 16,577 | 16,259 | $89K | |
| 86357 | 7,589 | 7,295 | $89K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 18,100 | 17,644 | $88K |
| 86757 | 6,103 | 5,794 | $87K | |
| 83014 | 35,739 | 34,925 | $86K | |
| 82787 | 9,767 | 9,412 | $85K | |
| 82330 | 24,077 | 22,738 | $83K | |
| 85018 | 121,670 | 115,190 | $82K | |
| 83010 | 28,977 | 27,800 | $82K | |
| 84238 | 7,687 | 7,484 | $80K | |
| 82668 | 12,035 | 11,754 | $80K | |
| 86015 | 15,767 | 15,249 | $80K | |
| 82374 | 40,009 | 38,356 | $80K | |
| 86356 | 6,678 | 6,423 | $79K | |
| 84134 | 23,554 | 19,322 | $78K | |
| 86870 | 10,763 | 10,050 | $77K | |
| 82525 | 20,632 | 19,831 | $77K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,527 | 2,360 | $76K |
| 82390 | 24,278 | 23,280 | $76K | |
| 83718 | 30,996 | 30,495 | $73K | |
| 80353 | 218,466 | 181,330 | $73K | |
| 82103 | 18,460 | 17,815 | $72K | |
| 80159 | 9,889 | 8,141 | $71K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 6,801 | 6,564 | $71K |
| 88189 | 3,905 | 3,797 | $70K | |
| 82164 | 18,704 | 18,057 | $70K | |
| 86335 | 8,066 | 7,734 | $69K | |
| 87631 | 1,433 | 1,371 | $69K | |
| 82955 | 18,507 | 18,132 | $69K | |
| 86162 | 13,038 | 12,530 | $67K | |
| 82653 | 6,081 | 5,945 | $66K | |
| 81500 | 1,126 | 1,103 | $66K | |
| 87538 | 7,110 | 6,898 | $66K | |
| ATP17 | 17,146 | 17,127 | $66K | |
| 86215 | 8,742 | 8,513 | $64K | |
| 84590 | 23,306 | 22,604 | $64K | |
| 84166 | 12,942 | 12,393 | $63K | |
| 85014 | 101,581 | 96,424 | $63K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,704 | 3,043 | $63K |
| 85246 | 12,363 | 11,881 | $62K | |
| 84244 | 12,031 | 11,580 | $61K | |
| 81361 | 7,159 | 6,701 | $59K | |
| 84482 | 12,556 | 12,178 | $58K | |
| 85245 | 11,348 | 10,896 | $57K | |
| 87109 | 8,587 | 8,371 | $56K | |
| 80202 | 10,251 | 4,742 | $56K | |
| 82679 | 5,194 | 5,086 | $55K | |
| 82610 | 14,373 | 13,954 | $55K | |
| 85379 | 18,760 | 17,988 | $54K | |
| 87184 | 8,656 | 8,207 | $51K | |
| 81255 | 7,446 | 6,985 | $51K | |
| 81251 | 7,490 | 7,030 | $50K | |
| 85240 | 12,540 | 12,063 | $50K | |
| 81206 | 2,236 | 2,175 | $49K | |
| 82140 | 12,031 | 10,995 | $48K | |
| 88311 | 14,938 | 14,456 | $48K | |
| 87476 | 3,987 | 3,832 | $48K | |
| 84446 | 13,409 | 13,150 | $48K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 9,819 | 9,345 | $46K |
| 88184 | 4,154 | 4,036 | $46K | |
| 82239 | 8,131 | 6,967 | $45K | |
| 80362 | 80,101 | 60,651 | $44K | |
| 81241 | 6,087 | 5,908 | $44K | |
| 86308 | 23,716 | 22,996 | $44K | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 10,689 | 10,331 | $44K |
| 81207 | 2,227 | 2,169 | $43K | |
| 81383 | 2,067 | 2,051 | $43K | |
| 82952 | 41,923 | 39,814 | $42K | |
| 82166 | 4,138 | 4,023 | $42K | |
| 84378 | 14,503 | 14,281 | $42K | |
| 81200 | 7,595 | 7,137 | $41K | |
| 86337 | 7,651 | 7,493 | $40K | |
| 82085 | 15,262 | 14,658 | $40K | |
| 84202 | 8,176 | 7,996 | $40K | |
| 80156 | 9,624 | 9,093 | $39K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 424 | 420 | $39K |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | 12,006 | 11,748 | $39K |
| 81412 | 128 | 124 | $38K | |
| 82308 | 2,509 | 2,442 | $38K | |
| 82232 | 8,299 | 7,904 | $38K | |
| 80175 | 11,690 | 11,253 | $37K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 18,142 | 17,227 | $37K |
| 87206 | 16,730 | 15,624 | $36K | |
| 81270 | 2,785 | 2,710 | $36K | |
| ATP03 | 9,292 | 9,259 | $36K | |
| 81330 | 7,509 | 7,046 | $34K | |
| 85598 | 8,937 | 8,573 | $34K | |
| 87076 | 11,143 | 10,625 | $33K | |
| 84255 | 3,894 | 3,644 | $33K | |
| 85384 | 10,576 | 10,025 | $33K | |
| 87254 | 4,924 | 4,670 | $32K | |
| ATP14 | 14,488 | 14,175 | $32K | |
| 83695 | 15,386 | 14,292 | $32K | |
| 82553 | 10,160 | 9,848 | $32K | |
| 87205 | 22,311 | 20,863 | $31K | |
| 80230 | 1,924 | 1,863 | $31K | |
| 81256 | 3,569 | 3,439 | $31K | |
| 86340 | 6,216 | 6,057 | $31K | |
| 87106 | 7,656 | 7,394 | $31K | |
| 82107 | 1,574 | 1,550 | $31K | |
| 83003 | 4,534 | 4,410 | $30K | |
| 80145 | 1,822 | 1,782 | $30K | |
| 84080 | 7,950 | 7,709 | $30K | |
| 80183 | 8,843 | 8,573 | $29K | |
| 87040 | 7,356 | 6,661 | $29K | |
| 80324 | 74,942 | 59,822 | $28K | |
| 82677 | 9,301 | 9,126 | $28K | |
| 83992 | 136,750 | 117,692 | $28K | |
| 84152 | 2,874 | 2,651 | $28K | |
| 84442 | 4,153 | 4,052 | $28K | |
| 85613 | 17,136 | 16,620 | $28K | |
| 83835 | 8,169 | 7,744 | $27K | |
| 87634 | 914 | 870 | $26K | |
| 80165 | 8,296 | 7,885 | $26K | |
| 81291 | 3,189 | 3,109 | $26K | |
| 82747 | 4,503 | 4,382 | $26K | |
| 81260 | 7,493 | 7,032 | $26K | |
| 81290 | 7,485 | 7,024 | $25K | |
| 81242 | 7,491 | 7,032 | $24K | |
| 83519 | 5,086 | 4,907 | $24K | |
| 80185 | 6,410 | 5,828 | $24K | |
| 87999 | 2,127 | 2,036 | $23K | |
| ATP08 | 11,187 | 10,737 | $23K | |
| ATP11 | 3,914 | 3,909 | $23K | |
| 82104 | 5,677 | 5,471 | $22K | |
| 87328 | 5,916 | 5,672 | $22K | |
| 85060 | 4,100 | 3,820 | $22K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 10,259 | 10,022 | $22K |
| 84591 | 7,013 | 6,820 | $22K | |
| 82642 | 3,003 | 2,926 | $22K | |
| 81219 | 444 | 438 | $22K | |
| 82552 | 5,299 | 5,076 | $22K | |
| 84484 | 6,268 | 5,890 | $22K | |
| 85306 | 5,185 | 5,047 | $21K | |
| 81517 | 593 | 578 | $21K | |
| 85597 | 5,051 | 4,808 | $21K | |
| 81209 | 7,523 | 7,066 | $21K | |
| 81240 | 4,083 | 3,967 | $21K | |
| 81402 | 246 | 242 | $20K | |
| 85004 | 15,234 | 13,549 | $20K | |
| 84143 | 1,762 | 1,709 | $20K | |
| 81244 | 3,741 | 3,690 | $20K | |
| 80320 | 6,036 | 5,376 | $19K | |
| ATP15 | 4,898 | 4,766 | $19K | |
| 82180 | 7,808 | 7,671 | $19K | |
| 89055 | 13,266 | 12,755 | $19K | |
| 86336 | 10,630 | 10,430 | $19K | |
| 85048 | 35,353 | 32,673 | $18K | |
| 81338 | 180 | 178 | $18K | |
| 80323 | 13,823 | 10,091 | $18K | |
| 84597 | 5,240 | 5,161 | $18K | |
| 86005 | 10,876 | 10,700 | $18K | |
| 86036 | 3,593 | 3,429 | $18K | |
| 82340 | 9,605 | 9,230 | $18K | |
| 80347 | 146,505 | 127,763 | $18K | |
| 86658 | 1,431 | 1,385 | $18K | |
| 86631 | 4,920 | 4,831 | $18K | |
| 87486 | 22,337 | 21,156 | $17K | |
| 83631 | 2,837 | 2,795 | $17K | |
| 87581 | 22,492 | 21,312 | $17K | |
| 80356 | 27,149 | 18,912 | $17K | |
| 83825 | 4,124 | 3,994 | $17K | |
| 86880 | 7,651 | 7,435 | $17K | |
| 83704 | 4,270 | 4,156 | $17K | |
| 83789 | 2,616 | 2,487 | $16K | |
| 82542 | 3,451 | 3,324 | $16K | |
| 88307 | 277 | 271 | $16K | |
| 85041 | 34,750 | 33,424 | $16K | |
| 85007 | 19,409 | 18,571 | $16K | |
| 87468 | 787 | 763 | $15K | |
| 80184 | 4,152 | 3,952 | $15K | |
| 83625 | 3,543 | 3,246 | $15K | |
| 80371 | 119,768 | 106,459 | $15K | |
| 80414 | 601 | 574 | $15K | |
| 88237 | 234 | 229 | $15K | |
| 83527 | 2,826 | 2,720 | $15K | |
| 80375 | 4,731 | 3,226 | $15K | |
| ATP13 | 1,899 | 1,883 | $14K | |
| ATP18 | 4,055 | 4,054 | $14K | |
| 80158 | 2,866 | 1,987 | $13K | |
| 82681 | 1,105 | 1,057 | $13K | |
| 0014M | 244 | 241 | $13K | |
| 84252 | 3,148 | 3,102 | $13K | |
| 82705 | 7,328 | 7,136 | $13K | |
| 85303 | 4,190 | 4,116 | $13K | |
| 85670 | 12,011 | 11,661 | $13K | |
| 84140 | 1,956 | 1,896 | $13K | |
| 87807 | 3,317 | 3,262 | $12K | |
| 87469 | 481 | 466 | $12K | |
| 0003M | 163 | 162 | $12K | |
| 80359 | 174,462 | 151,502 | $12K | |
| 87116 | 3,375 | 2,720 | $12K | |
| 82575 | 7,731 | 7,492 | $12K | |
| 86148 | 1,698 | 1,584 | $11K | |
| 80235 | 2,521 | 2,400 | $11K | |
| ATP10 | 3,016 | 2,949 | $11K | |
| 87015 | 3,642 | 3,121 | $11K | |
| 83930 | 4,893 | 4,602 | $11K | |
| 83935 | 6,692 | 6,412 | $10K | |
| 80337 | 123,294 | 108,181 | $10K | |
| 80195 | 2,850 | 2,332 | $10K | |
| 87420 | 3,032 | 2,864 | $10K | |
| 81279 | 97 | 97 | $10K | |
| 82384 | 2,965 | 2,780 | $10K | |
| ATP09 | 2,302 | 2,273 | $10K | |
| 87593 | 703 | 610 | $10K | |
| 80162 | 3,773 | 3,269 | $10K | |
| 85300 | 4,106 | 4,019 | $10K | |
| 87903 | 26 | 26 | $10K | |
| 80201 | 4,249 | 4,143 | $9K | |
| 82175 | 2,953 | 2,840 | $9K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 136 | 130 | $9K |
| 82657 | 1,323 | 1,277 | $9K | |
| 87425 | 1,855 | 1,805 | $9K | |
| ATP04 | 1,829 | 1,803 | $9K | |
| 80203 | 1,869 | 1,822 | $9K | |
| ATP07 | 2,601 | 2,570 | $9K | |
| 89060 | 3,262 | 3,085 | $9K | |
| 86682 | 1,867 | 1,819 | $9K | |
| 86804 | 1,424 | 1,306 | $9K | |
| 0024U | 1,507 | 1,422 | $8K | |
| 84300 | 7,195 | 6,896 | $8K | |
| 85049 | 5,941 | 5,206 | $8K | |
| 80364 | 118,938 | 106,467 | $8K | |
| 87496 | 751 | 599 | $8K | |
| 82530 | 2,674 | 2,577 | $8K | |
| 88271 | 309 | 300 | $8K | |
| 81405 | 101 | 94 | $8K | |
| 81364 | 273 | 265 | $7K | |
| 87102 | 2,616 | 2,473 | $7K | |
| 87467 | 450 | 433 | $7K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 2,203 | 2,159 | $7K |
| 87484 | 341 | 331 | $7K | |
| 82523 | 1,848 | 1,695 | $7K | |
| 99001 | 13,217 | 10,102 | $7K | |
| 80326 | 118,287 | 105,957 | $6K | |
| 82731 | 195 | 179 | $6K | |
| 80373 | 203,591 | 180,557 | $6K | |
| 83088 | 690 | 635 | $6K | |
| 88275 | 191 | 185 | $6K | |
| 87207 | 1,854 | 1,803 | $6K | |
| 80372 | 197,903 | 175,875 | $6K | |
| 84433 | 468 | 447 | $5K | |
| 83874 | 1,233 | 1,136 | $5K | |
| 85302 | 2,309 | 2,272 | $5K | |
| 89051 | 3,254 | 3,068 | $5K | |
| 85732 | 12,667 | 12,517 | $5K | |
| 86606 | 1,407 | 1,379 | $5K | |
| 85305 | 2,559 | 2,520 | $5K | |
| 80367 | 131,984 | 113,986 | $5K | |
| 86161 | 965 | 923 | $5K | |
| 86790 | 1,014 | 970 | $5K | |
| 80370 | 132,186 | 114,167 | $5K | |
| 80368 | 133,645 | 115,549 | $5K | |
| 86615 | 729 | 723 | $5K | |
| 86316 | 1,328 | 1,245 | $5K | |
| 86305 | 372 | 351 | $5K | |
| 87210 | 2,102 | 1,770 | $4K | |
| 82595 | 2,983 | 2,875 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 18,701 | 18,344 | $4K |
| 82379 | 1,940 | 1,895 | $4K | |
| 80338 | 122,457 | 107,489 | $4K | |
| 80360 | 122,223 | 107,345 | $4K | |
| 80344 | 121,674 | 107,015 | $4K | |
| 80366 | 143,040 | 122,289 | $4K | |
| 84133 | 3,198 | 3,076 | $4K | |
| 81332 | 224 | 211 | $4K | |
| 82656 | 1,274 | 1,262 | $4K | |
| 99199 | Unlisted special service, procedure or report | 10,609 | 9,155 | $4K |
| S3600 | Stat laboratory request (situations other than s3601) | 5,232 | 4,491 | $4K |
| ATP02 | 1,580 | 1,557 | $4K | |
| 80334 | 122,217 | 107,271 | $3K | |
| 87230 | 443 | 416 | $3K | |
| 81599 | 1,792 | 1,468 | $3K | |
| 82941 | 747 | 708 | $3K | |
| 80377 | 121,003 | 106,417 | $3K | |
| 86332 | 290 | 286 | $3K | |
| 0097U | 1,442 | 1,427 | $3K | |
| 85705 | 4,026 | 3,998 | $3K | |
| 80357 | 123,221 | 108,431 | $3K | |
| 83605 | 1,260 | 1,225 | $3K | |
| 80345 | 5,374 | 2,687 | $3K | |
| 0001M | 61 | 61 | $3K | |
| 81015 | 3,712 | 3,634 | $3K | |
| ATP16 | 636 | 616 | $3K | |
| 80355 | 142,821 | 122,121 | $3K | |
| 87252 | 506 | 501 | $3K | |
| 80331 | 117,588 | 105,297 | $3K | |
| 80369 | 853 | 713 | $3K | |
| 81443 | 1,468 | 1,456 | $2K | |
| 82436 | 2,045 | 1,990 | $2K | |
| 86611 | 1,465 | 1,455 | $2K | |
| 85247 | 704 | 688 | $2K | |
| 85385 | 1,478 | 1,417 | $2K | |
| 85301 | 1,461 | 1,446 | $2K | |
| 80220 | 511 | 478 | $2K | |
| 80341 | 121,808 | 107,192 | $2K | |
| 84260 | 254 | 243 | $2K | |
| 87511 | 87 | 82 | $2K | |
| 86041 | 271 | 265 | $2K | |
| 84560 | 1,230 | 1,197 | $2K | |
| 88289 | 953 | 946 | $2K | |
| 87905 | 993 | 942 | $2K | |
| 89321 | 933 | 859 | $2K | |
| 80325 | 359 | 300 | $2K | |
| 83986 | 1,742 | 1,692 | $2K | |
| 86226 | 345 | 334 | $2K | |
| 85307 | 307 | 296 | $2K | |
| 87168 | 768 | 762 | $2K | |
| 80352 | 105 | 84 | $2K | |
| 86703 | 153 | 152 | $2K | |
| 80169 | 326 | 257 | $1K | |
| 80374 | 3,293 | 2,760 | $1K | |
| 84145 | 135 | 128 | $1K | |
| 87172 | 633 | 596 | $1K | |
| ATP12 | 339 | 334 | $1K | |
| 82010 | 496 | 465 | $1K | |
| 88164 | 346 | 320 | $1K | |
| 80333 | 17 | 12 | $1K | |
| 84999 | 120 | 107 | $1K | |
| 86022 | 237 | 230 | $1K | |
| 86051 | 89 | 87 | $1K | |
| 82963 | 60 | 60 | $1K | |
| ATP05 | 204 | 202 | $1K | |
| 82300 | 395 | 381 | $1K | |
| 81422 | 5,797 | 5,791 | $895.68 | |
| 80503 | 100 | 95 | $856.15 | |
| 81408 | 40 | 39 | $773.36 | |
| 85549 | 83 | 80 | $735.61 | |
| 80332 | 10,202 | 6,966 | $728.75 | |
| 82373 | 88 | 83 | $728.09 | |
| 82540 | 986 | 963 | $724.18 | |
| 86710 | 223 | 217 | $714.54 | |
| 86692 | 338 | 330 | $710.12 | |
| 84206 | 89 | 77 | $707.69 | |
| 83937 | 49 | 39 | $672.37 | |
| 86794 | 55 | 54 | $648.81 | |
| 80150 | 88 | 24 | $647.42 | |
| 86906 | 146 | 144 | $639.19 | |
| 80171 | 134 | 116 | $606.60 | |
| 80376 | 351 | 297 | $575.33 | |
| 86309 | 133 | 130 | $567.76 | |
| 85250 | 206 | 202 | $529.98 | |
| ATP06 | 180 | 180 | $509.57 | |
| 84588 | 44 | 39 | $506.64 | |
| 85270 | 148 | 145 | $500.01 | |
| 82375 | 66 | 65 | $467.35 | |
| 85415 | 47 | 45 | $443.49 | |
| 84540 | 250 | 240 | $441.14 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 460 | 452 | $422.71 |
| 84105 | 310 | 303 | $393.01 | |
| 83698 | 42 | 34 | $386.71 | |
| 87912 | 12 | 12 | $359.13 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 21 | 21 | $331.24 |
| ATP19 | 97 | 97 | $324.06 | |
| 87899 | 55 | 54 | $322.13 | |
| 87110 | 43 | 43 | $308.38 | |
| 86366 | 31 | 28 | $281.90 | |
| 84181 | 53 | 51 | $272.51 | |
| ATP20 | 47 | 47 | $262.90 | |
| 82380 | 88 | 86 | $256.75 | |
| 80179 | 42 | 36 | $237.16 | |
| 36416 | 2,365 | 2,034 | $236.39 | |
| 82160 | 26 | 26 | $228.37 | |
| 80180 | 54 | 54 | $217.64 | |
| 83529 | 28 | 25 | $210.95 | |
| 86043 | 150 | 147 | $188.69 | |
| 80339 | 490 | 475 | $186.70 | |
| 86042 | 140 | 137 | $183.06 | |
| 80157 | 39 | 37 | $180.78 | |
| 88187 | 14 | 14 | $170.83 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 19 | 18 | $163.29 |
| 82108 | 12 | 12 | $139.13 | |
| 86602 | 52 | 50 | $133.42 | |
| 84585 | 182 | 180 | $130.60 | |
| 86849 | 244 | 225 | $114.94 | |
| 87449 | 156 | 156 | $109.65 | |
| 85230 | 13 | 13 | $108.85 | |
| 80186 | 30 | 28 | $108.71 | |
| 80200 | 14 | 12 | $104.09 | |
| 87149 | 20 | 13 | $97.62 | |
| 86609 | 247 | 245 | $93.75 | |
| 83945 | 195 | 192 | $81.26 | |
| 85220 | 13 | 13 | $80.40 | |
| 83497 | 55 | 54 | $79.38 | |
| 83915 | 12 | 12 | $75.25 | |
| 82270 | 58 | 51 | $67.61 | |
| 86001 | 89 | 87 | $60.13 | |
| 87140 | 31 | 30 | $54.99 | |
| 86331 | 40 | 39 | $53.78 | |
| 86632 | 1,818 | 1,810 | $50.04 | |
| 80198 | 14 | 13 | $42.74 | |
| 87299 | 1,179 | 1,160 | $40.11 | |
| 87279 | 1,178 | 1,159 | $33.47 | |
| 87276 | 1,188 | 1,169 | $33.01 | |
| 87280 | 1,186 | 1,167 | $30.65 | |
| 87260 | 1,178 | 1,159 | $30.05 | |
| 82365 | 742 | 737 | $29.92 | |
| 87275 | 1,188 | 1,169 | $29.75 | |
| 86628 | 43 | 43 | $27.21 | |
| 85420 | 12 | 12 | $25.23 | |
| 82360 | 342 | 340 | $16.52 | |
| 89160 | 13 | 12 | $15.96 | |
| 84163 | 1,983 | 1,976 | $13.74 | |
| 82139 | 2,099 | 2,045 | $13.50 | |
| 83919 | 818 | 816 | $13.16 | |
| 82945 | 13 | 12 | $12.43 | |
| 81162 | 116 | 116 | $0.00 | |
| 82017 | 1,196 | 1,193 | $0.00 | |
| 84311 | 58 | 58 | $0.00 | |
| 81373 | 48 | 48 | $0.00 | |
| 86352 | 223 | 223 | $0.00 | |
| 80327 | 94 | 94 | $0.00 | |
| 81400 | 14 | 14 | $0.00 | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 348 | 285 | $0.00 |
| ATP23 | 14 | 14 | $0.00 | |
| 82507 | 219 | 217 | $0.00 | |
| 99080 | 40,754 | 12,392 | $0.00 | |
| 83876 | 88 | 87 | $0.00 | |
| 88120 | 343 | 340 | $0.00 | |
| 83918 | 68 | 68 | $0.00 | |
| 82131 | 58 | 52 | $0.00 | |
| 84392 | 27 | 27 | $0.00 | |
| 83951 | 27 | 27 | $0.00 |